156 related articles for article (PubMed ID: 30442036)
1. Calcium Channel Blockers and the Risk for Lung Cancer: A Population-Based Nested Case-Control Study.
Rotshild V; Azoulay L; Feldhamer I; Perlman A; Glazer M; Muszkat M; Matok I
Ann Pharmacother; 2019 May; 53(5):445-452. PubMed ID: 30442036
[TBL] [Abstract][Full Text] [Related]
2. Calcium Channel Blocker Use and the Risk for Prostate Cancer: A Population-Based Nested Case-Control Study.
Rotshild V; Azoulay L; Feldhamer I; Perlman A; Muszkat M; Matok I
Pharmacotherapy; 2019 Jun; 39(6):690-696. PubMed ID: 30917404
[TBL] [Abstract][Full Text] [Related]
3. Calcium Channel Blockers in Secondary Cardiovascular Prevention and Risk of Acute Events: Real-World Evidence from Nested Case-Control Studies on Italian Hypertensive Elderly.
Bettiol A; Lucenteforte E; Vannacci A; Lombardi N; Onder G; Agabiti N; Vitale C; Trifirò G; Corrao G; Roberto G; Mugelli A; Chinellato A;
Clin Drug Investig; 2017 Dec; 37(12):1165-1174. PubMed ID: 28975522
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
Chang CH; Chiang CH; Yen CJ; Wu LC; Lin JW; Lai MS
J Hypertens; 2016 Mar; 34(3):558-66; discussion 566. PubMed ID: 26818924
[TBL] [Abstract][Full Text] [Related]
5. The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.
Mandilaras V; Bouganim N; Yin H; Asselah J; Azoulay L
Br J Cancer; 2017 Jan; 116(1):103-108. PubMed ID: 27846200
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Common Prescribing Cascade of Calcium Channel Blockers and Diuretics in Older Adults With Hypertension.
Savage RD; Visentin JD; Bronskill SE; Wang X; Gruneir A; Giannakeas V; Guan J; Lam K; Luke MJ; Read SH; Stall NM; Wu W; Zhu L; Rochon PA; McCarthy LM
JAMA Intern Med; 2020 May; 180(5):643-651. PubMed ID: 32091538
[TBL] [Abstract][Full Text] [Related]
7. Use of Calcium Channel Blockers and Risk of Active Tuberculosis Disease: A Population-Based Analysis.
Lee CC; Lee MG; Hsu WT; Park JY; Porta L; Liu MA; Chen SC; Chang SC
Hypertension; 2021 Feb; 77(2):328-337. PubMed ID: 33307850
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive medications and survival in patients with cancer: a population-based retrospective cohort study.
Holmes S; Griffith EJ; Musto G; Minuk GY
Cancer Epidemiol; 2013 Dec; 37(6):881-5. PubMed ID: 24075077
[TBL] [Abstract][Full Text] [Related]
9. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years.
Li CI; Malone KE; Weiss NS; Boudreau DM; Cushing-Haugen KL; Daling JR
Cancer; 2003 Oct; 98(7):1504-13. PubMed ID: 14508839
[TBL] [Abstract][Full Text] [Related]
10. Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.
Azoulay L; Soldera S; Yin H; Bouganim N
Epidemiology; 2016 Jul; 27(4):594-601. PubMed ID: 27031042
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
Bourgault C; Elstein E; Baltzan MA; Le Lorier J; Suissa S
Pharmacoepidemiol Drug Saf; 2001; 10(4):287-94. PubMed ID: 11760488
[TBL] [Abstract][Full Text] [Related]
13. Use of calcium channel blockers and myocardial infarction in hypertensive patients with rheumatoid arthritis - A nationwide cohort study.
Lin TT; Ko TY; Lin LY; Wu CK
J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):350-358. PubMed ID: 31257076
[TBL] [Abstract][Full Text] [Related]
14. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
15. Use of calcium channel blockers as antihypertensives in relation to mortality and cancer incidence: a population-based observational study.
Lindberg G; Lindblad U; Löw-Larsen B; Merlo J; Melander A; Råstam L
Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):493-7. PubMed ID: 12426934
[TBL] [Abstract][Full Text] [Related]
16. Association of calcium channel blockers with lower incidence of intracranial aneurysm rupture and growth in hypertensive patients.
Liu Q; Li J; Zhang Y; Leng X; Mossa-Basha M; Levitt MR; Wang S; Zhu C
J Neurosurg; 2023 Sep; 139(3):651-660. PubMed ID: 36708539
[TBL] [Abstract][Full Text] [Related]
17. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
[TBL] [Abstract][Full Text] [Related]
18. Association between use of antihypertensive drugs and the risk of cancer: a population-based cohort study in Shanghai.
Wang S; Xie L; Zhuang J; Qian Y; Zhang G; Quan X; Li L; Yu H; Zhang W; Zhao W; Qian B
BMC Cancer; 2023 May; 23(1):425. PubMed ID: 37165412
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers and myocardial infarction: a case--control study in a Japanese hospital.
Ohyama Y; Funao K; Kawabe E; Hayashi D; Yamazaki T; Iga T; Koide D; Ohe K; Kubota K
Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):487-92. PubMed ID: 12426933
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive drugs and the risk of idiopathic aplastic anaemia.
Myers MW; Vasilakis C; Kaufman MR; Jick H
Br J Clin Pharmacol; 2000 Jun; 49(6):604-8. PubMed ID: 10848725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]